This is to inform that due to some circumstances beyond the organizer control, “International Conference on Medicinal Chemistry, Computer Aided Drug Design and Delivery” (MCADD 2023) Hybrid event during September 14-16, 2023 at Valencia, Spain has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at medicinal-chemistry@magnusconference.com or call + 1 (702) 988 2320.
Pharmacology is the study of how chemicals interact with live organisms to impact their biochemical functioning. Potency is a measure of drug activity stated in terms of the amount necessary to generate an effect of a specific intensity in the discipline of pharmacology. At low doses, a highly potent medicine elicits a bigger reaction, whereas a substance of lower strength elicits a smaller response at identical concentrations. The design and implementation of an effective potent compound safety programme should follow the same basic process as traditional industrial hygiene programmes: hazards should be anticipated, activities with the potential for drug exposure should be identified and evaluated, and finally, these exposures should be controlled. If a chemical has an eight-hour time-weighted average occupational exposure limit (OEL) of 10 g/m3 or less, it is considered powerful in pharmacological terms. However, there is no formally agreed-upon definition of what defines a "highly potent" molecule at the OEL level. Individual risk assessors may classify the same substance differently, adding to the uncertainty.
Title : A qsar survey on tyrosine kinase inhibitors
Atefeh Hajiagha Bozorgi, Faculty of pharmacy, Iran (Islamic Republic of)
Title : Abbott diagnostics: COVID-19 inactivation, nucleocapsid antigen automated immunoassay development, and variant testing for automated and lateral flow assays binaxnow™ and panbio™
Philip M Hemken, Abbott Laboratories, United States
Title : Synthesis, antibacterial activity of 3-amino 5-methoxyl-2-methyl quinazolin-4(3H)-one an amino-6-methoxyl-2-methyl of 4H–benzo[d] [1,3]–oxazine–4–one
Osarumwense Peter Osarodion, Ondo State University of Sciences and Technology, Nigeria
Title : Tackling mycobacterium tuberculosis resistance with tailored isatin-pyrimidine hybrids enoyl acyl carrier protein reductase (Inha)
Amgad Albohy, The British University in Egypt (BUE), Egypt
Title : Transition metal complexes/Organometallic compounfs as anticancer drugs
Prakash kinthda, Nims university,jaipur,rajasthan, India
Title : New n-ribosides and n-mannosides of rhodanine derivatives with anticancer activity on leukaemia cell line: Design, synthesis, dft and molecular modelling studies
Ahmed, Kafrelsheikh University, Egypt